RemeGen’s Telitacicept Shows Positive Phase III Results in Rheumatoid Arthritis Study
China-based RemeGen Co., Ltd (HKG: 9995, SHA: 688331) has announced positive results from the China...
Shanxi Jinbo Bio-pharmaceutical Plans Fundraise with Private Placement and IPO Proceeds
China-based Shanxi Jinbo Bio-pharmaceutical Co., Ltd. (832982.BSE) is poised to raise RMB 36.75 million through...
CCDI Cartoon Exposes “Prescription Data Rebates” Corruption in China’s Healthcare System
China’s Central Commission for Discipline Inspection (CCDI), the country’s anti-graft bureau, has released a cartoon...
Roche Subsidiary Genentech Addresses Accidental Disclosure of Tiragolumab Trial Data
Swiss pharmaceutical major Roche (SWX: ROG), through its subsidiary Genentech, has released a statement addressing...
Shanghai Updates Biomedical R&D Import Pilot for Streamlined Customs Clearance
The Shanghai Municipal Commission of Commerce, in collaboration with Shanghai Customs and the Shanghai Municipal...
Bayer Partners with Mahana Therapeutics to Market Digital Health Technologies
Germany-headquartered Bayer (ETR: BAYN) has announced a strategic partnership with US digital developer Mahana Therapeutics....
European Commission Grants Conditional Approval for Janssen’s Talvey in Multiple Myeloma
The European Commission (EC) has granted conditional approval to Johnson & Johnson’s (J&J; NYSE: JNJ)...
Jiangsu Hengrui Pharmaceuticals’ Fluzoparib Files for New Indication with China’s NMPA
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276) has announced that the National Medical Products...
Kintor Pharmaceutical Completes Enrollment in Phase II Study of GT20029 for Androgenetic Alopecia
China-based Kintor Pharmaceutical Limited (HKG: 9939) has announced the completion of patient enrollment in a...
Novartis’s Leqvio (Inclisiran) Approved in China for Hypercholesterolemia Treatment
Swiss pharmaceutical giant Novartis (NYSE: NVS) has received approval from the National Medical Products Administration...
Novatim’s KQ-2003 and KY-0118 Advance with Clinical Trial Approvals in China
China-based cancer immunotherapy specialist Novatim Immune Therapeutics (Zhejiang) Co., Ltd has recently obtained clinical trial...
Sichuan Huiyu Pharmaceutical’s Plerixafor Gains Marketing Approval from Italian Medicines Agency
Sichuan Huiyu Pharmaceutical Co., Ltd (SHA: 688553), a China-based pharmaceutical company, has announced that it...
Lifetech Scientific Corporation Receives NMPA Approval for Epione Navigation System
China-based Lifetech Scientific Corporation (HKG: 1302) has announced that it has received market approval from...
Jiahui Health and Gleneagles Hong Kong Hospital Partner for Integrated Healthcare Services
China-based Jiahui Health has entered into a strategic partnership with Gleneagles Hong Kong Hospital to...
Saints Sages Surgical Secures Series B Funding to Advance Energy-Based Devices
Shanghai-based Saints Sages Surgical Co., Ltd, a leading developer of high-value minimally invasive surgical products,...
Hainan Huluwa Pharmaceutical Gets NMPA Approval for Generic Briviact Clinical Study
China-based Hainan Huluwa Pharmaceutical Group Co., Ltd (SHA: 605199) has announced that it has received...
CSPC Pharmaceutical Group Partners with Insilico and XtalPi for AI-Driven Drug R&D
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced strategic partnership agreements with Insilico Medicine...
Luye Pharma Group Submits Market Approval Filing for Lurbinectedin in Metastatic SCLC in Macau
China-based Luye Pharma Group (HKG: 2186) has announced that a market approval filing has been...
magAssist Receives FDA Breakthrough Device Designation for NyokAssist VAD
magAssist, a firm based in Suzhou, China, has announced that it has received breakthrough device...
Auzone Biological Technology Gets FDA Approval for Edaravone Oral Preparations in ALS
Suzhou Auzone Biological Technology Co., Ltd. has received approval from the US Food and Drug...